肺内亚实性结节的CT表现与病理相关性研究
Correlation Study between CT Manifestations and Pathological Features of Subsolid Pulmonary Nodules
DOI: 10.12677/acm.2026.161248, PDF,    科研立项经费支持
作者: 周仕怡*, 李正亮#:大理大学第一附属医院放射科,云南 大理;彭 璇:大理白族自治州妇幼保健院影像功能科,云南 大理
关键词: 亚实性结节磨玻璃结节计算机断层扫描病理Subsolid Nodule Ground-Glass Opacity Computed Tomography Pathology
摘要: 亚实性结节作为肺癌早期筛查的关键影像学表现,其诊断与治疗策略高度依赖CT技术,并与肺腺癌的病理特征密切相关。然而,由于目前肺结节在诊断中的阳性判断标准不一、成像参数存在差异,以及病理表现与影像特征之间的不一致,导致不同地区对同一病例的处理意见往往大相径庭。针对上述问题,本文系统综述了常规CT技术与新兴技术在亚实性结节良恶性鉴别中的应用现状与发展趋势。常规CT中,低剂量CT (LDCT)需结合特定人群调整判定阈值(如中国人群建议≥8 mm),双能量CT (DECT)有助于提升结节血供显示能力,而PET-CT主要用于确诊后的分期与治疗评估。新兴技术如人工智能与影像组学则通过将影像特征转化为定量数据,构建预测模型,以识别人眼难以察觉的细微特征。此外,本文还概述了肺结节的自然病程,并对比分析了不同国际指南在处理建议方面的异同。
Abstract: Subsolid nodules represent a critical imaging manifestation in early lung cancer screening, with their diagnosis and management being highly dependent on CT equipment and closely correlated with the pathology of lung adenocarcinoma. Current challenges in pulmonary nodule evaluation include inconsistent positive judgment criteria and variability in imaging parameters. To address these issues, this article systematically reviews the application of different CT technologies and emerging techniques in the differentiation of benign and malignant SSNs. In conventional CT, low-dose CT (LDCT) requires population-adjusted thresholds (e.g., optimized to ≥8 mm for Chinese populations), while dual-energy CT (DECT) enhances the visualization of nodular blood supply. PET-CT is primarily utilized for staging and treatment planning post-diagnosis. Emerging technologies such as artificial intelligence and radiomics facilitate the quantification of visual data, enabling the development of models that detect details imperceptible to the human eye. Finally, this review outlines the natural course of pulmonary nodules and compares the similarities and differences in management recommendations among international guidelines.
文章引用:周仕怡, 彭璇, 李正亮. 肺内亚实性结节的CT表现与病理相关性研究[J]. 临床医学进展, 2026, 16(1): 1961-1972. https://doi.org/10.12677/acm.2026.161248

参考文献

[1] Chen, H., Kim, A.W., Hsin, M., Shrager, J.B., Prosper, A.E., Wahidi, M.M., et al. (2024) The 2023 American Association for Thoracic Surgery (AATS) Expert Consensus Document: Management of Subsolid Lung Nodules. The Journal of Thoracic and Cardiovascular Surgery, 168, 631-647.e11. [Google Scholar] [CrossRef] [PubMed]
[2] Naidich, D.P., Bankier, A.A., MacMahon, H., Schaefer-Prokop, C.M., Pistolesi, M., Goo, J.M., et al. (2013) Recommendations for the Management of Subsolid Pulmonary Nodules Detected at CT: A Statement from the Fleischner Society. Radiology, 266, 304-317. [Google Scholar] [CrossRef] [PubMed]
[3] Im, J. (2024) Editorial Comment: Heterogeneous Ground-Glass Nodules (GGNs) Are between Pure GGNs and Part-Solid Nodules in Prognosis. American Journal of Roentgenology, 222, e2430990. [Google Scholar] [CrossRef] [PubMed]
[4] National Lung Screening Trial Research Team (2011) Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. The New England Journal of Medicine, 365, 395-409.
https://pubmed.ncbi.nlm.nih.gov/21714641/
[5] Pillay, J., Rahman, S., Klarenbach, S., et al. (2024) Screening for Lung Cancer with Computed Tomography: Protocol for Systematic Reviews for the Canadian Task Force on Preventive health Care. Systematic Reviews, 13, Article 88.
https://pubmed.ncbi.nlm.nih.gov/38493159/
[6] Henschke, C.I., McCauley, D.I., Yankelevitz, D.F., Naidich, D.P., McGuinness, G., Miettinen, O.S., et al. (1999) Early Lung Cancer Action Project: Overall Design and Findings from Baseline Screening. The Lancet, 354, 99-105. [Google Scholar] [CrossRef] [PubMed]
[7] Ye, W., Fu, W., Li, C., Li, J., Xiong, S., Cheng, B., et al. (2025) Diameter Thresholds for Pure Ground-Glass Pulmonary Nodules at Low-Dose CT Screening: Chinese Experience. Thorax, 80, 76-85. [Google Scholar] [CrossRef] [PubMed]
[8] Liu, B., Ye, X., Fan, W., et al. (2024) Expert Consensus on the Multidisciplinary Diagnosis and Treatment of Multiple Ground Glass Nodule-Like Lung Cancer (2024 Edition). Journal of Cancer Research and Therapeutics, 20, 1109-1123.
[9] MacMahon, H., Naidich, D.P., Goo, J.M., Lee, K.S., Leung, A.N.C., Mayo, J.R., et al. (2017) Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017. Radiology, 284, 228-243. [Google Scholar] [CrossRef] [PubMed]
[10] Prosper, A.E., Kammer, M.N., Maldonado, F., Aberle, D.R. and Hsu, W. (2023) Expanding Role of Advanced Image Analysis in CT-Detected Indeterminate Pulmonary Nodules and Early Lung Cancer Characterization. Radiology, 309, e222904. [Google Scholar] [CrossRef] [PubMed]
[11] Sun, J.D., Sugarbaker, E., Byrne, S.C., et al. (2024) Clinical Outcomes of Resected Pure Ground-Glass, Heterogeneous Ground-Glass, and Part-Solid Pulmonary Nodules. AJR. American Journal of Roentgenology, 222, e2330504.
https://pubmed.ncbi.nlm.nih.gov/38323785/
[12] Zhu, X., Shen, C. and Dong, J. (2024) A Clinically Applicable Model More Suitable for Predicting Malignancy or Benignity of Pulmonary Ground Glass Nodules in Women Patients. BMC Cancer, 24, Article No. 1225. [Google Scholar] [CrossRef] [PubMed]
[13] 双能量CT在肺部肿瘤中的应用和现状[EB/OL]. 国际放射医学核医学杂志.
https://metaersp-2.wust.edu.cn/s/com/yiigle/rs/G.https/cmaid/1155291, 2025-10-05.
[14] Chae, E.J., Song, J., Seo, J.B., Krauss, B., Jang, Y.M. and Song, K. (2008) Clinical Utility of Dual-Energy CT in the Evaluation of Solitary Pulmonary Nodules: Initial Experience. Radiology, 249, 671-681. [Google Scholar] [CrossRef] [PubMed]
[15] Yang, Y., Li, K., Sun, D., Yu, J., Cai, Z., Cao, Y., et al. (2019) Invasive Pulmonary Adenocarcinomas versus Preinvasive Lesions Appearing as Pure Ground-Glass Nodules: Differentiation Using Enhanced Dual-Source Dual-Energy Ct. American Journal of Roentgenology, 213, W114-W122. [Google Scholar] [CrossRef] [PubMed]
[16] Zhang, Y., Tang, J., Xu, J., Cheng, J. and Wu, H. (2017) Analysis of Pulmonary Pure Ground-Glass Nodule in Enhanced Dual Energy CT Imaging for Predicting Invasive Adenocarcinoma: Comparing with Conventional Thin-Section CT Imaging. Journal of Thoracic Disease, 9, 4967-4978. [Google Scholar] [CrossRef] [PubMed]
[17] 18F-FDG PET/CT不同重建方法对肺内病灶SUV及图像质量的影响[EB/OL]. 2025-03-25.
http://gfffh0ed7466bfba94363sqkqc9bo6vuw66k96.fffh.dali.cwkeji.cn/Periodical/gwyx-fsyxhyxfc202503004, 2025-10-07.
[18] Cuaron, J., Dunphy, M. and Rimner, A. (2013) Role of FDG-PET Scans in Staging, Response Assessment, and Follow-Up Care for Non-Small Cell Lung Cancer. Frontiers in Oncology, 2, Article ID: 208. [Google Scholar] [CrossRef] [PubMed]
[19] 蔡承伦, 杨云龙. 影像组学在肺肿瘤领域中的研究进展[J]. 肿瘤研究与临床, 2022, 34(7): 557-560.
[20] Qiu, Z., Wu, Q., Wang, S., Chen, Z., Lin, F., Zhou, Y., et al. (2022) Development of a Deep Learning‐Based Method to Diagnose Pulmonary Ground‐Glass Nodules by Sequential Computed Tomography Imaging. Thoracic Cancer, 13, 602-612. [Google Scholar] [CrossRef] [PubMed]
[21] Li, Y.J., Wang, Y. and Qiu, Z.X. (2024) Artificial Intelligence Research Advances in Discrimination and Diagnosis of Pulmonary Ground-Glass Nodules. Chinese Journal of Tuberculosis and Respiratory Diseases, 47, 566-570.
[22] Gong, J., Liu, J., Hao, W., Nie, S., Zheng, B., Wang, S., et al. (2019) A Deep Residual Learning Network for Predicting Lung Adenocarcinoma Manifesting as Ground-Glass Nodule on CT Images. European Radiology, 30, 1847-1855. [Google Scholar] [CrossRef] [PubMed]
[23] Sun, Q., Huang, Y., Wang, J., Zhao, S., Zhang, L., Tang, W., et al. (2019) Applying CT Texture Analysis to Determine the Prognostic Value of Subsolid Nodules Detected during Low-Dose CT Screening. Clinical Radiology, 74, 59-66. [Google Scholar] [CrossRef] [PubMed]
[24] Mei, K., Feng, Z., Liu, H., Wang, M., Ce, C., Yin, S., et al. (2025) Preoperative Prediction of Pulmonary Ground-Glass Nodule Infiltration Status by CT-Based Radiomics Combined with Neural Networks. BMC Cancer, 25, Article No. 659. [Google Scholar] [CrossRef] [PubMed]
[25] Yang, X., Wang, J., Wang, P., Li, Y., Wen, Z., Shang, J., et al. (2025) Deep Learning Model Using CT Images for Longitudinal Prediction of Benign and Malignant Ground-Glass Nodules. European Journal of Radiology, 190, Article 112252. [Google Scholar] [CrossRef] [PubMed]
[26] Seidelman, J.L., Myers, J.L. and Quint, L.E. (2013) Incidental, Subsolid Pulmonary Nodules at CT: Etiology and Management. Cancer Imaging, 13, 365-373. [Google Scholar] [CrossRef] [PubMed]
[27] Yoshizawa, A., Sumiyoshi, S., Sonobe, M., et al. (2013) Validation of the IASLC/ATS/ERS Lung Adenocarcinoma Classification for Prognosis and Association with EGFR and KRAS Gene Mutations: Analysis of 440 Japanese Patients. Journal of Thoracic Oncology, 8, 52-61.
[28] Koss, M.N., Fleming, M., Przygodzki, R.M., et al. (1998) Adenocarcinoma Simulating Mesothelioma: A Clinicopathologic and Immunohistochemical Study of 29 Cases. Annals of Diagnostic Pathology, 2, 93-102.
[29] Rossi, G., Murer, B., Cavazza, A., et al. (2004) Primary Mucinous (So-Called Colloid) Carcinomas of the Lung: A Clinicopathologic and Immuno-Histochemical Study with Special Reference to CDX-2 Homeobox Gene and MUC2 Expression. The American Journal of Surgical Pathology, 28, 442-452.
[30] Giesen, C., Del Águila Mejía, J., Armon, S., et al. (2024) Exploratory Evidence Maps for the WHO Classification of Tumours 5th Edition for Lung and Thymus Tumors. Virchows Archiv, 485, 869-878.
[31] Lee, G., Lee, H.Y., Jeong, J.Y., et al. (2015) Clinical Impact of Minimal Micropapillary Pattern in Invasive Lung Adenocarcinoma: Prognostic Significance and Survival Outcomes. The American Journal of Surgical Pathology, 39, 660-666.
[32] Inamura, K., Satoh, Y., Okumura, S., et al. (2005) Pulmonary Adenocarcinomas with Enteric Differentiation: Histologic and Immunohistochemical Characteristics Compared with Metastatic Colorectal Cancers and Usual Pulmonary Adenocarcinomas. The American Journal of Surgical Pathology, 29, 660-665.
https://pubmed.ncbi.nlm.nih.gov/15832091
[33] Gould, M.K., Tang, T., Liu, I.A., Lee, J., Zheng, C., Danforth, K.N., et al. (2015) Recent Trends in the Identification of Incidental Pulmonary Nodules. American Journal of Respiratory and Critical Care Medicine, 192, 1208-1214. [Google Scholar] [CrossRef] [PubMed]
[34] Mase, V.J. and Detterbeck, F.C. (2020) Approach to the Subsolid Nodule. Clinics in Chest Medicine, 41, 99-113. [Google Scholar] [CrossRef] [PubMed]
[35] Zhou, Y., Zhang, Y., Zhang, S., et al. (2023) Growth Regularity of Pulmonary Ground Glass Nodules Based on 3D Reconstruction Technology. Chinese Journal of Lung Cancer, 26, 265-273.
[36] Zhang, Z., Zhou, L., Min, X., Li, H., Qi, Q., Sun, C., et al. (2023) Long‐Term Follow‐Up of Persistent Pulmonary Subsolid Nodules: Natural Course of Pure, Heterogeneous, and Real Part‐Solid Ground‐Glass Nodules. Thoracic Cancer, 14, 1059-1070. [Google Scholar] [CrossRef] [PubMed]
[37] Kim, H., Cho, J.Y., Lee, Y.J., Park, J.S., Cho, Y., Yoon, H.I., et al. (2019) Clinical Significance of Pleural Attachment and Indentation of Subsolid Nodule Lung Cancer. Cancer Research and Treatment, 51, 1540-1548. [Google Scholar] [CrossRef] [PubMed]
[38] Borczuk, A.C. (2012) Assessment of Invasion in Lung Adenocarcinoma Classification, Including Adenocarcinoma in Situ and Minimally Invasive Adenocarcinoma. Modern Pathology, 25, S1-S10. [Google Scholar] [CrossRef] [PubMed]
[39] Nguyen, C., Larsen, N.K., Dietz, N., Sirineni, G. and Balters, M. (2019) Pulmonary Atypical Adenomatous Hyperplasia: Diagnostic and Therapeutic Implications. Cureus, 11, e6079. [Google Scholar] [CrossRef] [PubMed]
[40] Qiu, Z., Cheng, Y., Liu, D., Wang, W., Wu, X., Wu, W., et al. (2016) Clinical, Pathological, and Radiological Characteristics of Solitary Ground-Glass Opacity Lung Nodules on High-Resolution Computed Tomography. Therapeutics and Clinical Risk Management, 12, 1445-1453. [Google Scholar] [CrossRef] [PubMed]
[41] 中华医学会肿瘤学分会. 中华医学会肺癌临床诊疗指南(2024版) [J]. 中华医学杂志, 2024, 104(34): 3175-3213.
[42] Wood, D.E., Kazerooni, E.A., Baum, S.L., Eapen, G.A., Ettinger, D.S., Hou, L., et al. (2018) Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 16, 412-441. [Google Scholar] [CrossRef] [PubMed]